Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals’ (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid ...

Honeywell International is a diversified industrial conglomerate with four main segments: Aerospace, Industrial Automation, Building Automation, and Energy and Sustainability Solutions. The ...

Get Wall Street's Hottest Chart Every Morning RBC Capital Markets says Vertex management is optimistic about the recently approved Alyftrek. They predict that most of the 6,000 patients who ...

Honeywell (HON) is set to proceed with a breakup after facing continued pressure from activist Elliott Investment Management, Bloomberg’s David Carnevali reported on Monday. The industrial ...

Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.

Facing continued pressure from activist Elliott Investment Management, Honeywell (HON) is set to proceed with a breakup, people familiar with the matter Bloomberg’s David Carnevali. The ...

(Bloomberg) -- Honeywell International Inc. is poised to proceed with a breakup following pressure from activist Elliott Investment Management to split, people familiar with the matter said.

(Bloomberg) — Honeywell International Inc. is poised to proceed with a breakup following pressure from activist Elliott Investment Management to split, people familiar with the matter said. Honeywell ...

BOSTON, January 12, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the ...

Vertex Pharmaceuticals is hoping to build upon its existing rare blood disease treatment portfolio, teaming up with Orna Therapeutics’ ReNAgade in efforts to develop next-gen gene therapies for ...